Earendil Labs Funding: $787M Raised, Series B (2026)

Earendil Labs is based in Cambridge, Massachusetts. It has raised $787M in total funding. Latest round: Series B.

Earendil Labs funding overview

Earendil Labs is based in Cambridge, Massachusetts. Earendil Labs has raised $787M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in March 2026. The round record for Earendil Labs runs through 2026; nothing later has been disclosed. Investors on record include Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi and 1 others. 7 distinct backers are named across the disclosed rounds.

Earendil Labs at a glance

Total raised
$787M
Latest round
Series B
Latest round date
March 2026
Headquarters
Cambridge, Massachusetts
Notable investors
Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi, Biotech Development Fund

Frequently asked about Earendil Labs funding

How much has Earendil Labs raised?
Earendil Labs has raised $787M in total disclosed funding across the rounds on record.
Who has invested in Earendil Labs?
Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, Sanofi are named among the investors backing Earendil Labs.
What was the latest Earendil Labs funding round?
The most recent disclosed round is a Series B, announced in March 2026.
Where is Earendil Labs based?
Earendil Labs is based in Cambridge, Massachusetts.
When did Earendil Labs last raise?
The last disclosed Earendil Labs round closed in March 2026 at Series B.

Round data for Earendil Labs is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Companies related to Earendil Labs (21)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026